source
- Novo accelerates consumer focus with Wegovy pill launch and upcoming CagriSema, as marketing chief Ed Cinca returnsNovo is intensifying its consumer‑focused strategy, highlighted by the Wegovy oral pill and the forthcoming CagriSema product. The effort coincides with the return of senior vice president of mark…
- San Diego’s Seawolf Therapeutics raises $100M to develop non-viral gene therapies for obesity, muscle loss and osteoporosisSan Diego‑based Seawolf Therapeutics announced it has closed a $100 million financing round to fund its platform for non‑viral gene therapies. The company says its approach tackles a long‑standing…